These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18493606)
21. MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Qian S; Ding JY; Xie R; An JH; Ao XJ; Zhao ZG; Sun JG; Duan YZ; Chen ZT; Zhu B Biochem Biophys Res Commun; 2008 Dec; 377(2):668-673. PubMed ID: 18948085 [TBL] [Abstract][Full Text] [Related]
22. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related]
23. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy. Kim HK; Lee HY; Choi YL; Choi SJ; Choi H; Lee J; Han J; Ahn MJ; Lee KS; Kim J Anticancer Res; 2014 Feb; 34(2):707-14. PubMed ID: 24511003 [TBL] [Abstract][Full Text] [Related]
24. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137 [TBL] [Abstract][Full Text] [Related]
25. Stem cells for lung cancer? Berns A Cell; 2005 Jun; 121(6):811-3. PubMed ID: 15960966 [TBL] [Abstract][Full Text] [Related]
27. Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells. Janmaat ML; Rodriguez JA; Gallegos-Ruiz M; Kruyt FA; Giaccone G Int J Cancer; 2006 Jan; 118(1):209-14. PubMed ID: 16003751 [TBL] [Abstract][Full Text] [Related]
28. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development. Sharp TV; Al-Attar A; Foxler DE; Ding L; de A Vallim TQ; Zhang Y; Nijmeh HS; Webb TM; Nicholson AG; Zhang Q; Kraja A; Spendlove I; Osborne J; Mardis E; Longmore GD Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19932-7. PubMed ID: 19060205 [TBL] [Abstract][Full Text] [Related]
29. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630 [TBL] [Abstract][Full Text] [Related]
30. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer. Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187 [TBL] [Abstract][Full Text] [Related]
31. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features. Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071 [TBL] [Abstract][Full Text] [Related]
32. The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras. Ho VM; Schaffer BE; Karnezis AN; Park KS; Sage J Oncogene; 2009 Mar; 28(10):1393-9. PubMed ID: 19151761 [TBL] [Abstract][Full Text] [Related]
33. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency. Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114 [TBL] [Abstract][Full Text] [Related]
34. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732 [TBL] [Abstract][Full Text] [Related]
35. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer. Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324 [TBL] [Abstract][Full Text] [Related]
36. Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma. Ohba T; Toyokawa G; Osoegawa A; Hirai F; Yamaguchi M; Taguchi K; Seto T; Takenoyama M; Ichinose Y; Sugio K Surg Today; 2016 Sep; 46(9):1091-8. PubMed ID: 26711128 [TBL] [Abstract][Full Text] [Related]
37. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis. Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer. Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543 [TBL] [Abstract][Full Text] [Related]
39. Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells. Shao J; Evers BM; Sheng H Cancer Res; 2004 Jan; 64(1):229-35. PubMed ID: 14729629 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of OCT4 expression in adenocarcinoma of the lung. Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]